India CFO Summit :Watch India's top CFOs reveal how to mitigate financial risks and maintain business continuity on November 24, 2020 at 12pm. Register now!
you are here: HomeNewsBusiness
Last Updated : Mar 31, 2020 04:14 PM IST | Source: PTI

Coronavirus pandemic | Kalyani Group pledges Rs 25 crore to PM-CARES Fund

"The group is committed to assist the central and state government and the local authorities in all possible ways to deal with the pandemic. We are also using our group R&D facilities to look at ways of easing the shortage of critical medical equipment's, including ventilators, Respiratory equipment and other sanitation/hygiene equipment.

PTI
Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Pune-based Kalyani group on March 31 said it will contribute financial assistance worth Rs 25 crore to the Prime Minister's Citizen Assistance and Relief in Emergency Situations Fund (PM-CARES Fund) to fight against coronavirus pandemic.

Besides the flagship company Bharat Forge, the other Kalyani group companies are Kalyani Steel, Saarloha Advanced Material, Automotive Axles and Hikal Ltd.

Bharat Forge and other Kalyani Group companies have pledged assistance via direct contribution of Rs 25 Crores to the PM-CARES Fund to fight against the COVID-19 pandemic, the group said in a statement.

Close

"The group is committed to assist the central and state government and the local authorities in all possible ways to deal with the pandemic. We are also using our group R&D facilities to look at ways of easing the shortage of critical medical equipment's, including ventilators, Respiratory equipment and other sanitation/hygiene equipment.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
"As part of our CSR activity we have started addressing the food requirements of the local community and will increase the efforts in the coming days," Bharat Forge Chairman Baba Kalyani said.
First Published on Mar 31, 2020 04:10 pm
Sections